PIERONI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.743
NA - Nord America 4.527
EU - Europa 2.951
SA - Sud America 1.270
AF - Africa 232
OC - Oceania 168
Continente sconosciuto - Info sul continente non disponibili 1
Totale 17.892
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.423
CN - Cina 3.253
SG - Singapore 2.228
RU - Federazione Russa 1.532
KR - Corea 1.138
BR - Brasile 1.022
HK - Hong Kong 694
VN - Vietnam 683
IT - Italia 656
FR - Francia 210
JP - Giappone 181
AU - Australia 168
IN - India 158
FI - Finlandia 121
BD - Bangladesh 120
AR - Argentina 105
DE - Germania 102
TR - Turchia 79
NL - Olanda 67
NG - Nigeria 60
ID - Indonesia 58
CI - Costa d'Avorio 52
GB - Regno Unito 52
EC - Ecuador 44
IE - Irlanda 44
BJ - Benin 38
MX - Messico 36
CA - Canada 35
IQ - Iraq 34
SE - Svezia 34
CO - Colombia 29
UA - Ucraina 26
ZA - Sudafrica 23
VE - Venezuela 17
AT - Austria 16
ES - Italia 16
PL - Polonia 16
CL - Cile 15
PK - Pakistan 15
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
PY - Paraguay 13
MA - Marocco 12
UY - Uruguay 12
KE - Kenya 11
SA - Arabia Saudita 11
TN - Tunisia 10
AL - Albania 8
DO - Repubblica Dominicana 8
EG - Egitto 8
JO - Giordania 8
PA - Panama 8
DZ - Algeria 7
PE - Perù 7
LT - Lituania 6
NP - Nepal 6
RO - Romania 6
AZ - Azerbaigian 5
CR - Costa Rica 5
JM - Giamaica 5
PH - Filippine 5
GR - Grecia 4
HN - Honduras 4
IL - Israele 4
KW - Kuwait 4
KZ - Kazakistan 4
MY - Malesia 4
PS - Palestinian Territory 4
PT - Portogallo 4
QA - Qatar 4
TW - Taiwan 4
AO - Angola 3
BE - Belgio 3
BG - Bulgaria 3
BH - Bahrain 3
CH - Svizzera 3
HR - Croazia 3
HU - Ungheria 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GY - Guiana 2
LU - Lussemburgo 2
OM - Oman 2
RS - Serbia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LS - Lesotho 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
Totale 17.881
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.878
Singapore 1.786
Hefei 1.682
Seoul 1.137
Hong Kong 679
Ashburn 381
San Jose 320
Ho Chi Minh City 231
Tokyo 175
The Dalles 173
Lauterbourg 167
Melbourne 165
Kent 152
Hanoi 149
Buffalo 127
Los Angeles 117
Beijing 107
Bengaluru 99
Helsinki 99
Dallas 92
Council Bluffs 87
Moscow 85
New York 78
São Paulo 78
Rome 76
Florence 61
Abuja 58
Milan 58
Abidjan 52
Istanbul 46
Dublin 44
Haiphong 39
Cotonou 38
Munich 30
Fairfield 26
Naples 26
Orem 24
Da Nang 22
Frankfurt am Main 22
Belo Horizonte 21
Brasília 21
Rio de Janeiro 21
Jakarta 20
Biên Hòa 19
Chandler 19
Porto Alegre 19
Chicago 18
Seattle 18
Guayaquil 17
Nuremberg 17
Yubileyny 17
Bayreuth 15
Genoa 15
Guangzhou 15
Houston 15
Mudanya 15
Mumbai 15
Altamura 14
Curitiba 14
Hải Dương 14
Lappeenranta 14
Ribeirão Preto 14
Thái Bình 14
Bologna 13
Lawrence 13
London 13
Quito 13
Salvador 13
Thái Nguyên 13
Atlanta 11
Bắc Ninh 11
Dnipro 11
Guarulhos 11
Nairobi 11
Redondo Beach 11
Tashkent 11
Baghdad 10
Denver 10
Dhaka 10
Montreal 10
Paris 10
Tianjin 10
Warsaw 10
Johannesburg 9
Manaus 9
Ninh Bình 9
Recife 9
Shenzhen 9
Toronto 9
Wilmington 9
Woodbridge 9
Amsterdam 8
Boston 8
Buenos Aires 8
Cartagena 8
Chennai 8
Fortaleza 8
Mexico City 8
Panama City 8
Prato 8
Totale 11.436
Salva come PNG Salva come JPEG
Nome #
Position paper ANMCO: Cardiomiopatia ipertrofica: dalla diagnosi al trattamento 240
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 235
Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal 206
Screening for cardiac amyloidosis in patients with tenosynovial red flags: A collaboration between family medicine and cardiology 195
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 190
Update sulla gestione del paziente con cardiomiopatia ipertrofica alla luce delle nuove linee guida nord-americane 181
Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry 173
An expert consensus document on the management of cardiovascular manifestations of Fabry disease 172
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 170
Anderson-Fabry disease management: Role of the cardiologist 165
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 155
Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies 154
Differential Diagnoses in Clinical Mimics 153
From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy 150
The Italian Fabry Disease Cardiovascular Registry (IFDCR) 150
Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama 147
The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG Signs 146
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week 145
Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments 143
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 138
Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management 137
Genotype-Negative Patients With Familial Hypertrophic Cardiomyopathy 133
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 128
The spectrum of myocarditis: from pathology to the clinics 128
3D-electroanatomic mapping-guided endomyocardial biopsy findings in patients with Brugada syndrome 127
Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies 125
Binary Sign in Anderson-Fabry Cardiomyopathy 122
Aging and diabetes do not deplete the pool of cardiac stem cells in patients with ischemic cardiomyopathy 122
Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy Plus Apical Ballooning: Management With VA-ECMO and Myectomy 122
Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias 120
Takotsubo (Stress) Cardiomyopathy 120
Atypical Subendocardial Late Gadolinium Enhancement in Anderson-Fabry Cardiomyopathy 118
Active lymphocytic myocarditis: virologic and immunologic profile of responders versus non-responders to immunosuppressive therapy 115
Myocarditis and COVID-19 related issues 113
Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 110
An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins 105
Baseline NT-Pro-BNP Levels and Arrhythmia Recurrence in Outpatients Undergoing Elective Cardioversion of Persistent Atrial Fibrillation: A Survival Analysis. Indian Pacing Electrophysiol J 105
High Prevalence of Myocarditis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy Differential Diagnosis by Electroanatomic Mapping-Guided Endomyocardial Biopsy 105
Myocardial production of Chromogranin A: a new regulatory peptide of myocyte function 103
Lone HCV myocarditis responsive to immunosuppressive therapy 103
Early detection of Fabry cardiomyopathy by tissue - Doppler imaging 102
European expert consensus statement on therapeutic goals in Fabry disease 101
Inflammatory left ventricular microaneurysms associated with apparently idiopathic ventricular tachyarrhythmias 101
Prognostic Value of Non-Ischemic Ring-Like Left Ventricular Scar in Patients with Apparently Idiopathic Non-Sustained Ventricular Arrhythmias. 101
Cardiological follow-up in patients with Fabry disease 100
HIGH EXERCISE-INDUCED PLATELET REACTIVITY IN PATIENTS WITH ANDERSON-FABRY'S DISEASE 100
Active lymphocytic myocarditis: Virologic and immunologic profile of responder's vs non-responders to immunosuppressive therapy 99
Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2 98
'Hissing snake' left ventricle thrombotic phase of hypereosinophilic endomyocardial disease 98
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 98
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 97
Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy 97
Syndrome of reversible cardiogenic shock and left ventricular ballooning in obstructive hypertrophic cardiomyopathy 97
Inflammatory left ventricular microaneurysms associated with apparently idiopathic ventricular tachyarrhythmias 96
Myocarditis: when to suspect and how to diagnose it in athletes 96
Morpho-functional Correlates of the Electroanatomic Abnormalities in Arrhythmogenic Right Ventricular Cardiomyopathy 96
Intramyocyte detection of Epstein Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy 94
Histologic findings in patients with clinical and instrumental diagnosis of arrhythmogenic right ventricular dysplasia 94
Continuous positive airway pressure treatment in addition to optimal medical therapy for ventricular ectopy in a patient with heart failure and sleep-related breathing disorder 93
Association of Heart Rate Variability With Arrhythmic Events in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 93
Ventricular arrhythmias induced by long-term use of ephedrine in two competitive athletes 93
Correction to: Clinical staging of Anderson‑Fabry cardiomyopathy: an operative proposal 93
Myocardial and Microvascular Stunning in Apical Ballooning Syndrome 92
Cell mechanisms of cardiac recovery in patients with inflammatory cardiomyopathy responding to immunosuppressive therapy 92
Electroanatomic and histologic findings in patients with clinical and instrumental diagnosis of arrhythmogenic right ventricular cardiomyopathy 91
Senescence and death of primitive cells and myocytes leads to premature cardiac ageing and heart failure 91
Myocardial inflammation in hypertrophic cardiomyopathy patients presenting acute clinical deterioration 91
Letter by Pieroni et al regarding article, "Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy" 91
Left-Dominant Arrhythmogenic Cardiomyopathy 90
Association of parvovirus b19 at the culprit coronary stenosis with clinical outcome after coronary stenting 90
Early detection of Fabry cardiomyopathy by tissue Doppler imaging 90
Celiac disease associated with autoimmune myocarditis 90
Myocardial gene expression profiling in Fabry cardiomyopathy 89
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts 89
Myocardial Inflammation in Brugada Syndrome 89
Early detection of Fabry cardiomyopathy by tissue - Doppler imaging 89
High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathy. 88
Progression of electroanatomic substrate and electric storm recurrence in a patient with Brugada syndrome 88
Prevalence and prognostic value of structural abnormalities in Brugada syndrome 88
Correlation Between Signal-Averaged Electrocardiogram and the Histologic Evaluation of the Myocardial Substrate in Right Ventricular Outflow Tract Arrhythmias 88
Histologic findings in patients with clinical and instrumental diagnosis of arrhythmogenic right ventricular dysplasia 88
Intramyocyte detection of Epstein Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy 87
Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study 87
Right ventricular substrate mapping using the Ensite Navx system: Accuracy of high-density voltage map obtained by automatic point acquisition during geometry reconstruction 87
Brugada Syndrome in the Young and in the Adult: A Tale of 2 Diseases? 87
Smooth muscle cells in human atherosclerotic plaque secrete HMGB1, and proliferate in response to it 86
Biventricular endomyocardial biopsy findings in patients with Brugada syndrome 86
Relation Between Signal-Averaged Electrocardiogram and Electroanatomic Mapping in Arrhythmogenic Right Ventricular Cardiomyopathy 85
Active lymphocytic myocarditis: virologic and immunologic profile of responders versus non-responders to immunosuppressive therapy 85
Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy 84
Brain natriuretic peptide in hypertrophic cardiomyopathy with and without systolic dysfunction 84
Capitolo 20. Cardiomiopatie e pericarditi nell'atleta 84
Histologic determinants of diastolic dysfunction in patients with Fabry cardiomyopathy 83
Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia 83
CApitolo 7. Cardiomiopatie e Miocarditi 83
High Exercise-Induced Platelet Reactivity in Patients with Fabry Disease 83
High Prevalence of Active Myocarditis in Patients with Takotsubo Cardiomyopathy: A Magnetic Resonance-endomyocardial Biopsy Study 83
Histologic findings in patients with clinical and instrumental diagnosis of arrhythmogenic right ventricular dysplasia 83
Late-onset primary LVH: HCM versus cardiac Fabry variant 82
Recovery of normal ventricular function in patients with dilated cardiomyopathy: relevance of the etiology. 82
Totale 11.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 6 2
2021/202252 2 2 5 2 1 2 3 3 6 8 2 16
2022/2023147 12 33 6 4 7 26 29 8 10 6 5 1
2023/2024155 1 9 17 8 9 24 7 31 4 20 20 5
2024/20256.319 32 103 362 912 1.476 1.157 119 145 499 212 487 815
2025/202611.378 1.134 2.117 2.583 1.673 565 234 919 542 629 559 423 0
Totale 18.127